The pleiotropic transcription factor NF-B controls cellular apoptotic and growth processes and increasing evidence suggests a role in tumorigenesis. We describe here that constitutively activated NF-B complexes are found in the vast majority (39 out of 42 samples) of childhood acute lymphoblastic leukemia (ALL) without any subtype restriction. Electrophoretic shift analysis further demonstrates that these complexes are composed of p50-p50 and p65-p50 dimers. Proteasome inhibition in primary ALL cultures results in a hyperphosphorylated form of IB␣, indicating that activation of upstream kinases, which trigger IB␣ degradation, has led to nuclear translocation of NF-B. Careful inhibition of cellular proteolytic activities is of importance when analyzing extracts from primary ALL cells. Degradation of p65 and other proteins in ALL samples could be specifically suppressed by ␣-1 antitrypsin. Constitutive NF-B activation is thus a common characteristic of childhood ALL and strongly suggests a critical role of this factor for leukemia cell survival. Leukemia (2000) 14, 399-402.
Introduction
The NF-B family of transcription factors has important regulatory functions for both normal and malignant hematopoiesis in many species and plays important roles in the immune system. 1, 2 Murine knockout models of NF-B and IB genes have shown specific roles for lymphocyte development and function. 3 Accumulating evidence indicates a role of NF-B and IB proteins in growth control and oncogenesis. 4 Homo-and heterodimers of the NF-B subunits p50, p52, p65, c-Rel, and RelB are under control of the inhibitory IB proteins IB␣, IB␤, IB⑀, p105 and p100. 5 Prototypic NF-B p50-p65 is sequestered in the cytoplasm by IB␣, ␤ or ⑀ and is released after stimulation through various signal transduction pathways which induce degradation of the IBs. Tumor necrosis factor ␣ (TNF␣), interleukin-1 (IL-1) and other agents induce phosphorylation of IBs by IB kinases at conserved serines residues which triggers subsequent ubiquitination and destruction of the inhibitors by the proteasome. 5 In most cell types, signalinduced translocation of NF-B into the nucleus and activation of transcription is only transient. However, constitutively active nuclear NF-B containing the c-Rel and RelB subunits, is found in mature B cells and correlates with enhanced turnover of IB␣. 2 Constitutively activated NF-B p50-p65 has been observed in neurons and in primary cells or cell lines derived from Hodgkin's disease (HD), adult T cell leukemia (ATL), breast carcinoma, melanoma and pancreatic adenocarcinoma. [6] [7] [8] [9] [10] [11] In the context of neoplastic diseases, it is relevant that NF-B p50-p65 suppresses apoptosis and mounts a pro- tective response against anthracyclines and topo-II-isomerase inhibitors.
12-14 NF-B further regulates cell adhesion molecules, tissue plasminogen activator, and cyclins, 1, 15, 16 and controls the cell cycle by affecting the Rb pathway. 16 We have previously shown that inhibition of NF-B indeed strongly increases apoptosis rate and slows down cell proliferation in Hodgkin/Reed-Sternberg cells. 7 Constitutive NF-B activation in HD is caused by persistently activated IB kinases and, in some cases, by mutated IB␣. [17] [18] [19] Acute lymphoblastic leukemia (ALL) is the most common cancer in childhood and comprises a heterogeneous group of malignant clonal disorders originating from B-or less commonly from T-progenitor cells. ALL subgroups with distinct biological characteristics are frequently characterized by deregulated transcription factors or kinases, most prominently the fusion proteins TEL-AML1 encoded by t(12;21)(p13;q22) in presumedly good risk ALL, or BCR-ABL encoded by t(9;22)(q34;q11) and MLL-AF4 by t(4;11)(q21;q23) in high risk ALL. 20 When screening various pediatric tumors for aberrant NF-B activities, we found that ALL cells at diagnosis typically contain constitutively activated p50-p65 heterodimers and p50 homodimers. Furthermore, kinases acting on IB␣ were activated in the vast majority of ALL samples investigated.
Materials and methods

Cell culture
Primary ALL samples from peripheral blood or bone marrow aspirates (Robert-Rö ssle-Klinik, MDC, Berlin) and mononuclear cells from normal peripheral blood were purified by Ficoll gradient centrifugation. A few samples were thawed and washed after cryopreservation. Cell viability was assessed by trypan blue exclusion and was mostly greater than 90%. An initial round of cryopreserved samples was obtained from the laboratory at the University-Childrens-Hospital, Charité, Berlin (KH Seeger). ALL cells were kept in short-term culture in RPMI 1640 (Gibco, Karlsruhe, Germany), 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin/streptomycin. L1236 and HDLM-2 HD cells were grown in the same medium. SEM and uocb-1 ALL cells were kindly provided by R Marschalek, University Erlangen, and by T Look, SJCRH, Memphis, TN, USA, respectively. 50 nM phorbol-12-myristate-13-acetate (PMA; Sigma, St Louis, MO, USA) or 50 g/ml N-acetyl-leucyl-leucyl-norleucinal (ALLN; Calbiochem, San Diego, CA, USA) was added where indicated.
Electrophoretic mobility shift assay (EMSA) and Western blotting
Whole cell extracts were prepared as described 21 with 3 g/l ␣-1 antitrypsin in the extraction buffer. After washing cells with PBS, lysis buffer (20 mM HEPES pH 7.9, 350 mM NaCl, 0.5 mM EDTA, 0.1 mM EGTA, 1 mM MgCl 2 , 10% glycerol, 1% Nonidet P-40, 1 g/ml pefabloc, 1 g/ml aprotinin, 1 g/ml leupeptin, 1 g/ml pepstatin A, 10 mM NaF, 8 mM glycerophosphate, and 1 mM DTT) was added. After 10 min at 4°C the lysate was centrifuged for 5 min at 15 800 g in a microfuge. EMSA was performed as described. 21 Western blots were analyzed by chemiluminescense following the manufacturer's recommendations (New England Biolabs, Beverly, MA, USA). Antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA) (IB␣, p65, c-Rel and RelB), Rockland (p50) and Upstate Biotechnology (Lake Placid, NY USA) (p52). 1 g of purified recombinant wild-type IB␣ was added where indicated.
Results and discussion
The analysis of NF-B activity in ALL cells from patients at diagnosis was initially hampered by proteolysis in about half of the samples, even though a standard broad-spectrum inhibitor cocktail was used during extract preparation. This led to abrogation of both Oct-1 and NF-B DNA binding activities and to truncation of p65 and IB␣ proteins ( Figure 1 ). By mixing extracts of the HD cell line HDLM-2 with a proteolytically active ALL extract lacking Oct-1 and NF-B activities and testing various protease inhibitors, we determined that ␣-1-antitrypsin was best in preserving the shift activity ( Figure 1) .
We compared NF-B DNA binding activity in ALL samples to that found in HD cells (L1236) or in control mononuclear 14) were antipain dihydrochloride (4.8 mM), bestatin (2.7 mM), chymostatin (5.5 mM), E-64 (0.9 mM), leupeptin (0.33 mM), pepstatin (0.2 mM), phosphoramidon (3.3 mg/ml), pefabloc (26 mM), EDTA (18 mM), aprotinin (1.6 mg/ml) (all purchased from Boehringer), ␣-1 antitrypsin (Sigma) (3 mg/ml), DEVD-chlormethylketone (Bachem) (50 M).
cells from healthy probands, using ␣-1-antitrypsin in the extraction buffer (Figure 2 ). Results were standardized against Oct-1 shift activity as an internal control for each sample (Figure 2b) . 39 of 42 samples invariably showed constitutively activated NF-B in comparison to unstimulated cell lines (not shown) or normal mononuclear cells (Figure 2a) . Constitutive NF-B in ALL appears to be a general characteristic since there was no correlation with immunophenotype, disease at primary diagnosis or relapse, or good or poor prednisone responders. NF-B activation in ALL was similar to that in HD cell lines. Unstimulated peripheral blood mononuclear cells isolated from healthy probands displayed some faint NF-B activity, possibly accounting for the mature B cell population, but this activity could be strongly stimulated by phorbol-12-myristate-13-acetate (PMA). In contrast, constitutive NF-B activities in HD cells and half of the ALL cells tested were refractory to strong superstimulation by PMA, indicating close to maximal NF-B activation (Figure 1a) .
Constitutive NF-B activity in ALL consisted of p50-p65 heterodimers and of p50 homodimers, as determined by supershift analysis with antibodies directed against p65, p50, p52, c-Rel or RelB (Figure 2c ). Addition of wild-type recombinant IB␣ to the DNA binding reaction inhibited the p50-p65 but, as expected, not p50-p50 complexes, indicating that the observed constitutive activity was not due to mutations or modifications that render NF-B resistant to IB␣ (Figure 2c) . Furthermore, p65 displayed a normal migration in Western blots (not shown).
If constitutive NF-B is caused by activated signaling cascades acting upstream of IB␣ in ALL cells, phosphorylated IB␣ should be stabilized upon inhibition of the proteasome. ALL cells were kept in medium with or without N-acetyl-leucyl-leucyl-norleucinal (ALLN). Cellular extracts were prepared and probed with an anti-IB␣ antibody in Western blots. Unlike in Hodgkin cells, [17] [18] [19] IB␣ consistently had the wildtype length (Figure 2d and data not shown). In 18 out of 19 samples analyzed, a slower migrating phosphoform of IB␣ was stabilized in the presence of ALLN (Figure 2d ), indicating that upstream kinases were indeed activated. Similarly, phosphorylated IB␣ was stabilized by ALLN in HD cells (Figure 2d and Ref. 17). We were not able to induce NF-B in control cell lines by supernatants of ALL cell cultures (data not shown) and consider it unlikely that NF-B activation is caused by an autocrine mechanism. Our data thus indicate that constitutive activation of NF-B in ALL is caused by ongoing signaling in these cells which leads to persistent activation of IB kinases. It will have to be addressed in future studies whether mutations in signaling molecules upstream of IB␣ have been accumulated in these cells.
Mori et al 11 reported that NF-B is constitutively activated in an apparently HTLV-1-Tax-independent manner in seven primary adult T cell leukemia (ATL) samples and in one ATLderived cell line. In contrast, we failed to detect constitutive NF-B activation in several transformed ALL cell lines analyzed (Reh, Blin, SEM, Uocb-1) (data not shown). It is possible that constitutive NF-B is activated in ALL and ATL by the same mechanisms. Hematopoietic tumors in adults contain rearrangements or amplifications of members of the NF-B/IB gene families in up to 25%, 4 however this is not the case for childhood ALL. 22 The bcr-abl product of the highrisk translocation (9;22)(q34;q11) in ALL has been shown to activate NF-B through an as yet unknown target in the NF-B/IB pathway. 23, 24 It is present in 5% of childhood ALL, 20% of relapsed childhood ALL and 30% of adult ALL, and thus can account for NF-B activation in some, but not all ALLs.
The clonal evolution of malignant lymphoblasts in ALL has to escape safeguards that control normal proliferation and differentiation in lymphopoiesis and ensure delivery of functional mature lymphocytes. While some transcription factors are deregulated by certain hallmark translocations in subtypes of childhood ALL and in fact allow stratification into different therapeutic regimens, no such factor has been shown to be uniformly involved. We propose that general constitutive actiLeukemia vation of NF-B in ALL serves as an important switch that ensures survival of ALL cells either by blocking apoptosis or by enhancing proliferation.
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